Capital Group Private Client Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Sell
51,628
-6,018
-10% -$1.29M 0.18% 54
2026
Q1
$12.5M Sell
57,646
-3,514
-6% -$779K 0.21% 56
2025
Q4
$14M Buy
61,160
+6,065
+11% +$1.38M 0.22% 62
2025
Q3
$12.8M Sell
55,095
-209,169
-79% -$42.6M 0.21% 68
2025
Q2
$49.1M Sell
264,264
-179,467
-40% -$33.4M 0.42% 58
2025
Q1
$93M Sell
443,731
-18,096
-4% -$3.52M 0.91% 26
2024
Q4
$82.1M Sell
461,827
-14,230
-3% -$2.62M 0.76% 33
2024
Q3
$94M Sell
476,057
-21,282
-4% -$3.97M 0.9% 28
2024
Q2
$85.3M Sell
497,339
-6,987
-1% -$1.16M 0.85% 29
2024
Q1
$91.8M Buy
504,326
+254,309
+102% +$43.8M 0.94% 28
2023
Q4
$38.7M Buy
250,017
+58,530
+31% +$8.53M 0.4% 75
2023
Q3
$28.5M Buy
191,487
+9,083
+5% +$1.33M 0.35% 88
2023
Q2
$24.6M Sell
182,404
-2,726
-1% -$400K 0.29% 96
2023
Q1
$29.5M Buy
185,130
+18,148
+11% +$2.77M 0.37% 87
2022
Q4
$27M Sell
166,982
-2,400
-1% -$368K 0.34% 85
2022
Q3
$22.7M Sell
169,382
-122
-0.1% -$17.5K 0.32% 89
2022
Q2
$26M Buy
169,504
+41,726
+33% +$6.38M 0.34% 84
2022
Q1
$20.7M Buy
+127,778
New +$18.6M 0.23% 106

Other funds holding ABBV

Capital Group Private Client Services's ABBV Position: Q2 2026 in Review

Capital Group Private Client Services reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $1.29M and leaving 51,628 shares worth $13M. The position accounts for 0.18% of the portfolio, ranked #54.

Capital Group Private Client Services first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $94M in Q3 2024. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Capital Group Private Client Services held 51,628 shares of AbbVie worth $13M as of Q2 2026.
  • Capital Group Private Client Services sold 6,018 AbbVie shares in Q2 2026, an estimated $1.29M.
  • AbbVie made up 0.18% of Capital Group Private Client Services's portfolio in Q2 2026, its #54 holding.
  • Capital Group Private Client Services first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • Capital Group Private Client Services's AbbVie position peaked at $94M in Q3 2024.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capital Group Private Client Services's 13F filing for Q2 2026, filed 12 Aug 2026.